FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3097155917> ?p ?o ?g. }

• W3097155917 endingPage "21" @default.
• W3097155917 startingPage "14" @default.
• W3097155917 abstract "FMX101 4% minocycline is a hydrophobic, topical foam formulation of minocycline recently approved by the United States Food and Drug Administration (FDA) for the treatment of non-nodular inflammatory lesions in moderate-to-severe acne vulgaris. It was developed to harness the anti-inflammatory and antibiotic activity of minocycline while minimizing potentially serious systemic adverse events associated with oral delivery. The composition and profile of this novel treatment have yet to be described. This article discusses the components of the foam-based product and the rationale for their selection. It reviews microbiologic data for FMX101 4% and presents previously unpublished data regarding sebum penetration, minocycline permeation, and disposition into skin structures. The effects of FMX101 4% were compared with those of several commercially available acne preparations to determine how the FMX101 4% formulation affects the physical properties of model human sebum in vitro. The hydrophobic formulation of FMX101 4% was found to lower the melting temperature of model human sebum below that of normal skin temperature, decreasing its viscosity. FMX101 4% achieved high concentrations of minocycline in the sebaceous appendage, while minimizing permeation beyond the dermal layer. Finally, this article summarizes efficacy and safety data for FMX101 4% from three Phase III studies (FX2014-04, FX2014-05, and FX2017-22). FMX101 4% appeared to be safe, effective, and well tolerated for the treatment of non-nodular inflammatory lesions in moderate-to-severe acne vulgaris. In conclusion, the topical formulation of minocycline in FMX101 4% represents a unique treatment for acne vulgaris and a viable alternative to oral administration." @default.
• W3097155917 created "2020-11-09" @default.
• W3097155917 creator A5006377781 @default.
• W3097155917 creator A5007581860 @default.
• W3097155917 creator A5008772023 @default.
• W3097155917 creator A5031277996 @default.
• W3097155917 creator A5044704538 @default.
• W3097155917 creator A5052575200 @default.
• W3097155917 creator A5058903008 @default.
• W3097155917 creator A5059112028 @default.
• W3097155917 creator A5089319958 @default.
• W3097155917 date "2020-04-01" @default.
• W3097155917 modified "2023-10-10" @default.
• W3097155917 title "Formulation and Profile of FMX101 4% Minocycline Topical Foam for the Treatment of Acne Vulgaris." @default.
• W3097155917 cites W1952330277 @default.
• W3097155917 cites W1975464841 @default.
• W3097155917 cites W1988958914 @default.
• W3097155917 cites W2000157399 @default.
• W3097155917 cites W2018009008 @default.
• W3097155917 cites W2021517382 @default.
• W3097155917 cites W2071275152 @default.
• W3097155917 cites W2085727074 @default.
• W3097155917 cites W2096780638 @default.
• W3097155917 cites W2112151566 @default.
• W3097155917 cites W2133961780 @default.
• W3097155917 cites W2138816688 @default.
• W3097155917 cites W2140862701 @default.
• W3097155917 cites W2153752818 @default.
• W3097155917 cites W2162467127 @default.
• W3097155917 cites W2171863770 @default.
• W3097155917 cites W2252882781 @default.
• W3097155917 cites W2276726626 @default.
• W3097155917 cites W2351080806 @default.
• W3097155917 cites W2419535666 @default.
• W3097155917 cites W2543379137 @default.
• W3097155917 cites W2585999703 @default.
• W3097155917 cites W2728446638 @default.
• W3097155917 cites W2767747595 @default.
• W3097155917 cites W2781148444 @default.
• W3097155917 cites W2888882167 @default.
• W3097155917 cites W2894458010 @default.
• W3097155917 cites W2946877589 @default.
• W3097155917 cites W2980340322 @default.
• W3097155917 cites W3004092144 @default.
• W3097155917 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7605387" @default.
• W3097155917 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33144907" @default.
• W3097155917 hasPublicationYear "2020" @default.
• W3097155917 type Work @default.
• W3097155917 sameAs 3097155917 @default.
• W3097155917 citedByCount "3" @default.
• W3097155917 countsByYear W30971559172021 @default.
• W3097155917 countsByYear W30971559172023 @default.
• W3097155917 crossrefType "journal-article" @default.
• W3097155917 hasAuthorship W3097155917A5006377781 @default.
• W3097155917 hasAuthorship W3097155917A5007581860 @default.
• W3097155917 hasAuthorship W3097155917A5008772023 @default.
• W3097155917 hasAuthorship W3097155917A5031277996 @default.
• W3097155917 hasAuthorship W3097155917A5044704538 @default.
• W3097155917 hasAuthorship W3097155917A5052575200 @default.
• W3097155917 hasAuthorship W3097155917A5058903008 @default.
• W3097155917 hasAuthorship W3097155917A5059112028 @default.
• W3097155917 hasAuthorship W3097155917A5089319958 @default.
• W3097155917 hasConcept C16005928 @default.
• W3097155917 hasConcept C197934379 @default.
• W3097155917 hasConcept C2777673923 @default.
• W3097155917 hasConcept C2778275353 @default.
• W3097155917 hasConcept C3020248838 @default.
• W3097155917 hasConcept C501593827 @default.
• W3097155917 hasConcept C71924100 @default.
• W3097155917 hasConcept C86803240 @default.
• W3097155917 hasConcept C89423630 @default.
• W3097155917 hasConcept C98274493 @default.
• W3097155917 hasConceptScore W3097155917C16005928 @default.
• W3097155917 hasConceptScore W3097155917C197934379 @default.
• W3097155917 hasConceptScore W3097155917C2777673923 @default.
• W3097155917 hasConceptScore W3097155917C2778275353 @default.
• W3097155917 hasConceptScore W3097155917C3020248838 @default.
• W3097155917 hasConceptScore W3097155917C501593827 @default.
• W3097155917 hasConceptScore W3097155917C71924100 @default.
• W3097155917 hasConceptScore W3097155917C86803240 @default.
• W3097155917 hasConceptScore W3097155917C89423630 @default.
• W3097155917 hasConceptScore W3097155917C98274493 @default.
• W3097155917 hasIssue "4" @default.
• W3097155917 hasLocation W30971559171 @default.
• W3097155917 hasOpenAccess W3097155917 @default.
• W3097155917 hasPrimaryLocation W30971559171 @default.
• W3097155917 hasRelatedWork W2078072344 @default.
• W3097155917 hasRelatedWork W2158300404 @default.
• W3097155917 hasRelatedWork W2260885322 @default.
• W3097155917 hasRelatedWork W2289092041 @default.
• W3097155917 hasRelatedWork W2327044349 @default.
• W3097155917 hasRelatedWork W2340222847 @default.
• W3097155917 hasRelatedWork W2413614809 @default.
• W3097155917 hasRelatedWork W2552572772 @default.
• W3097155917 hasRelatedWork W3118330055 @default.
• W3097155917 hasRelatedWork W4234749278 @default.
• W3097155917 hasVolume "13" @default.
• W3097155917 isParatext "false" @default.

• next